Prevention of free fatty acid‐induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Liver international (Print)

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1478-3231.2011.02602.xPMID 22093454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysis

  2011cited by this paper
• Carnitine palmitoyltransferase I control of acetogenesis, the major pathway of fatty acid {beta}-oxidation in liver of neonatal swine.

  2010cited by this paper
• Oral acetyl-L-carnitine therapy and insulin resistance.

  2010cited by this paper
• Oral carnitine therapy and insulin resistance.

  2010cited by this paper
• l-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis—A Randomized and Controlled Clinical Trial

  2010influential reference
• Effects of carnitine on peripheral blood mitochondrial DNA copy number and liver function in non-alcoholic fatty liver disease.

  2010influential reference
• Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism.

  2009cited by this paper
• Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications

  2009cited by this paper
• The lysosomal‐mitochondrial axis in free fatty acid–induced hepatic lipotoxicity

  2008cited by this paper
• Short- and medium-chain carnitine acyltransferases and acyl-CoA thioesterases in mouse provide complementary systems for transport of β-oxidation products out of peroxisomes

  2008cited by this paper
• l-Carnitine Treatment Reduces Steatosis in Patients with Chronic Hepatitis C Treated with α-Interferon and Ribavirin

  2008cited by this paper
• Long term highly saturated fat diet does not induce NASH in Wistar rats

  2007cited by this paper
• Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.

  2007cited by this paper
• Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.

  2007cited by this paper
• A combination of caffeine, arginine, soy isoflavones, and L-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo.

  2007influential reference
• Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

  2006cited by this paper
• Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study.

  2006cited by this paper
• NASH: a mitochondrial disease.

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• [Histologic grading and staging of chronic hepatitis: on the basis of standardized guideline proposed by the Korean Study Group for the Pathology of Digestive Diseases].

  2003cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Mitochondria in Steatohepatitis

  2001cited by this paper
• Peroxisomal beta-oxidation and steatohepatitis.

  2001cited by this paper
• The spectrum of liver disease in the general population: lesson from the Dionysos study.

  2001cited by this paper
• Peripheral blood mitochondrial DNA content is inversely correlated with insulin secretion during hyperglycemic clamp studies in healthy young men.

  2001cited by this paper
• Peroxisomal β-Oxidation and Steatohepatitis

  2001cited by this paper
• Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases.

  1998cited by this paper
• [Phase II study].

  1995cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper
• Ameliorating effects of carnitine and its precursors on alcohol-induced fatty liver.

  1984cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Liver Pathology and the Metabolic Syndrome X in

  year unknowncited by this paper

• Neuroprotective effects of L-carnitine towards oxidative stress and inflammatory processes: a review of its importance as a therapeutic drug in some disorders

  2025influential citation
• Effects of l-carnitine, taurine and vitamin E in cellular Non-alcoholic fatty liver disease models

  2025cites this paper
• Role of L-Carnitine in Exercise Training: Anti-Inflammatory, Antioxidant, and Metabolic Interactions

  2025cites this paper
• Hepatic Ketogenesis Regulates Lipid Homeostasis via ACSL1-mediated Fatty Acid Partitioning

  2025cites this paper
• Lipoic acid in metabolic dysfunction-associated steatotic liver disease: a review

  2025cites this paper
• Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes

  2025cites this paper
• Lipidomics and transcriptomics analysis revealed the role of the spleen of Nile tilapia (Oreochromis niloticus) in lipid metabolism

  2024cites this paper
• Integrated analysis reveals the regulatory mechanism of the neddylation inhibitor MLN4924 on the metabolic dysregulation in rabbit granulosa cells

  2024cites this paper
• Thyroid Hormone-Mediated Selective Autophagy and Its Implications in Countering Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Serum macroelements and microelements levels in periparturient dairy cows in relation to fatty liver diseases

  2024cites this paper
• L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review

  2024cites this paper
• Hepatic ketogenesis regulates lipid homeostasis via ACSL1-mediated fatty acid partitioning

  2023cites this paper
• Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis

  2023cites this paper
• Replacement Flame-Retardant 2-Ethylhexyldiphenyl Phosphate (EHDPP) Disrupts Hepatic Lipidome: Evidence from Human 3D Hepatospheroid Cell Culture

  2023cites this paper
• Dietary l-carnitine regulates liver lipid metabolism via simultaneously activating fatty acid β-oxidation and suppressing endoplasmic reticulum stress in large yellow croaker fed with high-fat diets

  2022cites this paper
• Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

  2022cites this paper
• Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study

  2022cites this paper
• Fatty liver and risk of dementia NAFLD increases a risk of stroke DPP-4 inhibitor-specific biomarkers in NAFLD LPS promotes HCC by NETs formation via TLR4 CLIF-SOFA score and sepsis

  2022cites this paper
• Exogenous L-carnitine ameliorates burn-induced cellular and mitochondrial injury of hepatocytes by restoring CPT1 activity

  2021cites this paper
• Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cells

  2021cites this paper
• Exogenous L-carnitine a meliorated burn-induced cellular and mitochondrial injuries of hepatocytes via recovering CPT1 activity

  2021cites this paper
• Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update

  2021cites this paper
• Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases

  2021cites this paper
• Dissecting the Gene Expression Networks Associated with Variations in the Major Components of the Fatty Acid Semimembranosus Muscle Profile in Large White Heavy Pigs

  2021cites this paper
• Maternal Obesity Alters circRNA Expression and the Potential Role of mmu_circRNA_0000660 via Sponging miR_693 in Offspring Liver at Weaning Age.

  2020cites this paper
• Chapter 9: Carnitine

  2020cites this paper
• Influenza virus infection affects insulin signaling, fatty acid-metabolizing enzyme expressions, and the tricarboxylic acid cycle in mice

  2020cites this paper
• L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet.

  2020cites this paper
• ARHGAP21-deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese mice.

  2019cites this paper
• Analyzing Mitochondrial Dysfunction, Oxidative Stress, and Apoptosis: Potential Role of L-carnitine.

  2019cites this paper
• Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats

  2019cites this paper
• Histological and immunohistochemical study on the effect of valporic acid on the bone of adult male guinea pigs and the possible protective role of L-carnitine

  2019cites this paper
• Adipocyte Fatty Acid-Binding Protein Promotes Palmitate-Induced Mitochondrial Dysfunction and Apoptosis in Macrophages

  2018cites this paper
• ShenFu Preparation Protects AML12 Cells Against Palmitic Acid-Induced Injury Through Inhibition of Both JNK/Nox4 and JNK/NFκB Pathways

  2018cites this paper
• Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation

  2018cites this paper
• Palmitic acid induces ceramide accumulation, mitochondrial protein hyperacetylation, and mitochondrial dysfunction in porcine oocytes†

  2018cites this paper
• Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats

  2018cites this paper
• L‐carnitine prevents metabolic steatohepatitis in obese diabetic KK‐Ay mice

  2017cites this paper
• Mitochondrial Oxidative Stress and Calcium-Dependent Permeability Transition are Key Players in the Mechanisms of Statins-Associated Side Effects

  2017cites this paper
• Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease

  2017cites this paper
• L-CARNITINE SUPPLEMENTATION ATTENUATES NAFLD PROGRESSION AND COMPLICATIONS IN A METHIONINE AND CHOLINE DEFICIENT DIET MOUSE MODEL

  2017cites this paper
• Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways

  2017cites this paper
• Evaluation of L-Carnitine Efficacy in the Treatment of Non-Alcoholic Fatty Liver Disease among Diabetic Patients: A Randomized Double Blind Pilot Study

  2016cites this paper
• l-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats

  2016cites this paper
• Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.

  2015cites this paper
• Antioxidant Action of Carnitine: Molecular Mechanisms and Practical Applications

  2015cites this paper
• Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes.

  2015cites this paper
• Carnitine Enigma: From Antioxidant Action to Vitagene Regulation. Part 2. Transcription Factors and Practical Applications

  2015cites this paper
• Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial

  2015cites this paper
• L-Carnitine Ameliorates Cancer Cachexia in Mice Partly via the Carnitine Palmitoyltransferase-Associated PPAR-γ Signaling Pathway

  2015cites this paper
• Carnitine Enigma: From Antioxidant Action to Vitagene Regulation. Part 1. Absorption, Metabolism, and Antioxidant Activities

  2015cites this paper
• Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.

  2014cites this paper
• Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD

  2014cites this paper
• Effect of carnitine‐orotate complex on glucose metabolism and fatty liver: A double‐blind, placebo‐controlled study

  2014cites this paper
• Systems biology applied to non-alcoholic fatty liver disease (NAFLD): treatment selection based on the mechanism of action of nutraceuticals

  2014cites this paper
• Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study

  2013cites this paper
• Protective effects of l-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin.

  2013cites this paper
• Free radical biology for medicine: learning from nonalcoholic fatty liver disease.

  2013cites this paper
• Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.

  2013influential citation
• Lipoic Acid Prevents the Changes of Intracellular Lipid Partitioning by Free Fatty Acid

  2013cites this paper
• Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients?

  2013cites this paper
• Activation of the mitochondrial ATP-sensitive K+ channel reduces apoptosis of spleen mononuclear cells induced by hyperlipidemia

  2013cites this paper
• Treatments for mitochondrial dysfunction associated with autism spectrum disorders

  2012cites this paper
• Gene Expression Profiling of Soft and Firm Atlantic Salmon Fillet

  2012cites this paper
• The role of fatty acid metabolism and lipotoxicity in pancreatic β-cell injury: Identification of potential therapeutic targets

  2012cites this paper